Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W C Nichols

Showing results (51-60 of 78) with videos related to

Pageof 8
Sort By:
British Journal of Haematology|October 1, 1996
A common frameshift mutation in von Willebrand factor does not alter mRNA stability but interferes with normal propeptide processingK L Mohlke, W C Nichols, A Rehemtulla, et al.
Blood|August 15, 1996
Moderation of hemophilia A phenotype by the factor V R506Q mutationW C Nichols, K Amano, P M Cacheris, et al.
The Journal of Clinical Investigation|April 1, 1991
The molecular defect in type IIB von Willebrand disease. Identification of four potential missense mutations within the putative GpIb binding domainK A Cooney, W C Nichols, M E Bruck, et al.
Neurology|March 12, 2003
Heterozygosity for a mutation in the parkin gene leads to later onset Parkinson diseaseT Foroud, S K Uniacke, L Liu, et al.
Nature Genetics|September 6, 2000
Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension, K B Lane, R D Machado, et al.
Neurology|July 29, 2009
Parkin dosage mutations have greater pathogenicity in familial PD than simple sequence mutationsN Pankratz, D K Kissell, M W Pauciulo, et al.
Neurology|September 7, 2007
LRRK2 mutation analysis in Parkinson disease families with evidence of linkage to PARK8W C Nichols, V E Elsaesser, N Pankratz, et al.
The Journal of Clinical Investigation|December 1, 1990
A point mutation in transthyretin increases affinity for thyroxine and produces euthyroid hyperthyroxinemiaA C Moses, H N Rosen, D E Moller, et al.
Cancer Clinical Trials|January 1, 1981
An evaluation of low-dose cisplatin as part of combined modality therapy of limited small cell lung cancerR T Eagan, R E Lee, S Frytak, et al.
Neurology|November 7, 2008
Mutations in GBA are associated with familial Parkinson disease susceptibility and age at onsetW C Nichols, N Pankratz, D K Marek, et al.
Pageof 8

Showing results (51-60 of 78) with videos related to

Sort By:
Pageof 8
British Journal of Haematology|October 1, 1996
A common frameshift mutation in von Willebrand factor does not alter mRNA stability but interferes with normal propeptide processingK L Mohlke, W C Nichols, A Rehemtulla, et al.
Blood|August 15, 1996
Moderation of hemophilia A phenotype by the factor V R506Q mutationW C Nichols, K Amano, P M Cacheris, et al.
The Journal of Clinical Investigation|April 1, 1991
The molecular defect in type IIB von Willebrand disease. Identification of four potential missense mutations within the putative GpIb binding domainK A Cooney, W C Nichols, M E Bruck, et al.
Neurology|March 12, 2003
Heterozygosity for a mutation in the parkin gene leads to later onset Parkinson diseaseT Foroud, S K Uniacke, L Liu, et al.
Nature Genetics|September 6, 2000
Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension, K B Lane, R D Machado, et al.
Neurology|July 29, 2009
Parkin dosage mutations have greater pathogenicity in familial PD than simple sequence mutationsN Pankratz, D K Kissell, M W Pauciulo, et al.
Neurology|September 7, 2007
LRRK2 mutation analysis in Parkinson disease families with evidence of linkage to PARK8W C Nichols, V E Elsaesser, N Pankratz, et al.
The Journal of Clinical Investigation|December 1, 1990
A point mutation in transthyretin increases affinity for thyroxine and produces euthyroid hyperthyroxinemiaA C Moses, H N Rosen, D E Moller, et al.
Cancer Clinical Trials|January 1, 1981
An evaluation of low-dose cisplatin as part of combined modality therapy of limited small cell lung cancerR T Eagan, R E Lee, S Frytak, et al.
Neurology|November 7, 2008
Mutations in GBA are associated with familial Parkinson disease susceptibility and age at onsetW C Nichols, N Pankratz, D K Marek, et al.
Pageof 8